JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases
JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases
Not yet recruiting · NCT06567080 · Registry updated 2024-08-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, large B-cell lymphoma, systemic lupus erythematosus | Not yet recruiting | Phase 1 | 2024-08-22 | NCT06567080 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| RenJi Hospital | 264 |
| Shanghai Ming Ju Biotechnology Co., Ltd. | 7 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Renji Hospital, Shanghai Jiaotong University School of Medicine | Shanghai | China | 6 |